NewCode Oncology is a Toronto‑based precision oncology company building the next generation of cancer diagnostics and clinical decision support. The company has developed an AI‑powered, whole‑transcriptome (RNA‑Seq) universal tumor classifier that leverages the full RNA signal of a tumor—rather than limited gene panels—to accurately determine cancer type, prognosis, and therapeutic direction.